PlainPharmaWatch

CMS Open Payments · Tool

Baylis Medical Technologies Inc. vs KOELIS Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Baylis Medical Technologies Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,658, versus 1,315 for the other company. Its single largest recorded recipient represents 38.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Baylis Medical Technologies Inc.
HHI 2,658 · top recipient 38.4%
Ranked #622 of 1,838 companies by HHI
KOELIS Inc.
HHI 1,315 · top recipient 23.8%
Ranked #913 of 1,838 companies by HHI

Payment Overview

Total Payments
$71.7K
% of Industry
0.0%
Transactions
168
Avg per Transaction
$426.71
Recipients
168
Avg per Recipient
$426.71
Payment Types
2
Top Payment Type
Consulting Fee
Company B

KOELIS Inc.

Total Payments
$73.0K
% of Industry
0.0%
Transactions
234
Avg per Transaction
$311.78
Recipients
234
Avg per Recipient
$311.78
Payment Types
3
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Baylis Medical Technologies Inc. vs KOELIS Inc. - total reported payments in CMS Open Payments PY2024

KOELIS Inc.$73.0KBaylis Medical Technologies…$71.7K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Baylis Medical Technologies Inc.

Consulting Fee $67.5K

94.2%

Food and Beverage $4.2K

5.8%

KOELIS Inc.

Consulting Fee $48.9K

67.1%

Food and Beverage $13.5K

18.5%

Travel and Lodging $10.5K

14.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Baylis Medical Technologies Inc.

  1. 1

    TIMOTHY CLARK

    $27,550.00 · 1 txns

  2. 2

    MARCELO GUIMARAES

    $22,619.00 · 4 txns

  3. 3

    VENU VADLAMUDI

    $8,804.00 · 4 txns

  4. 4

    MARTIN RADVANY

    $2,468.40 · 5 txns

  5. 5

    JOSEPH GEMMETE

    $2,400.00 · 4 txns

KOELIS Inc.

  1. 1

    Amir Hossein Lebastchi

    $17,381.10 · 24 txns

  2. 2

    Jonathan S Fainberg

    $12,322.15 · 14 txns

  3. 3

    Michael Arya Daneshvar

    $10,255.24 · 12 txns

  4. 4

    Kyrollis Attalla

    $9,563.30 · 9 txns

  5. 5

    Andre Luis De Castro Abreu

    $5,788.41 · 4 txns

Summary Comparison

Metric Baylis Medical Technologies Inc. KOELIS Inc.
Total Payments $71.7K $73.0K
% of Industry Total 0.0% 0.0%
Transaction Count 168 234
Avg per Transaction $426.71 $311.78
Recipient Count 168 234
Avg per Recipient $426.71 $311.78
Payment Type Count 2 3
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.